Download Files:
Sapacitabine
SKU
HY-16445-10 mg
Category Reference compound
Tags Cancer, Cell Cycle/DNA Damage, Nucleoside Antimetabolite/Analog
$75 – $600
Products Details
Product Description
– Sapacitabine is an orally available nucleoside analog proagent that is structurally related to cytarabine.
Web ID
– HY-16445
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C26H42N4O5
References
– [1]Serova M, et al. Antiproliferative effects of sapacitabine (CYC682), a novel 2′-deoxycytidine-derivative, in human cancer cells. Br J Cancer. 2007 Sep 3;97(5):628-36.|[2]Green SR, et al. Combination of sapacitabine and HDAC inhibitors stimulates cell death in AML and other tumour types. Br J Cancer. 2010 Oct 26;103(9):1391-9.
CAS Number
– 151823-14-2
Molecular Weight
– 490.64
Compound Purity
– 98.13
SMILES
– O=C(N=C(NC(CCCCCCCCCCCCCCC)=O)C=C1)N1[C@H]2[C@@H](C#N)[C@H](O)[C@@H](CO)O2
Clinical Information
– Phase 3
Research Area
– Cancer
Solubility
– DMSO : 33.33 mg/mL (ultrasonic)
Target
– Nucleoside Antimetabolite/Analog
Pathway
– Cell Cycle/DNA Damage
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.